Electronic Arts and Respawn Entertainment have announced a new major event happening this year for Apex Legends esports, as the inaugural ALGS Open will take place this May as part of the Year 5 ...
Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of $3.41 per share versus the Zacks Consensus Estimate of a loss of $1.91. This compares to loss of $5.50 per share a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback